Sunday, 14 June 2026European Markets

#Cellular Intelligence

2 articles

Novo Nordisk Licenses Parkinson's Therapy to AI Startup, Shares Rise 24.9% in 30 Days

European Pharmaceutical Innovation

Novo Nordisk Licenses Parkinson's Therapy to AI Startup, Shares Rise 24.9% in 30 Days

Salvado•Jun 5, 2026

Novo Nordisk Closes Cell Therapy Unit, Outsources Parkinson's to AI Partner as Stock Surges 25%

European Pharmaceutical Innovation

Novo Nordisk Closes Cell Therapy Unit, Outsources Parkinson's to AI Partner as Stock Surges 25%

Salvado•May 18, 2026